managing adverse events of novel antibody-drug conjugates in breast cancer
Published 2 months ago • 4 plays • Length 18:35Download video MP4
Download video MP3
Similar videos
-
37:59
antibody-drug conjugates in the spotlight: novel strategies for breast cancer management
-
18:25
emerging antibody-drug conjugates in breast cancer: an expert analysis of promising therapies
-
37:44
clinical perspectives on her2-targeted antibody-drug conjugates: treatment-related adverse events
-
10:21
novel antibody-drug conjugates (adcs) technologies for management of mbc
-
1:51
managing adc-related toxicity in breast cancer
-
51:16
research month: antibody drug conjugates in breast cancer
-
35:25
antibody drug conjugates and recent applications in breast cancer treatment
-
17:52
how can broadening knowledge in bioconjugate design & development help treat oncology & beyond?
-
40:12
improving patient outcomes in urothelial carcinoma with novel antibody–drug conjugates
-
1:11
development of antibody-drug conjugate therapies in breast cancer
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
5:00
hematologic adverse events with adcs in breast cancer: optimal management strategies
-
1:29:20
experts discuss antibody-drug conjugates in breast, lung, & gi cancers - https://bit.ly/3rkkvzm
-
25:46
antibody drug conjugates present and future applications in breast cancer
-
3:42
antibody drug conjugates in metastatic breast cancer | anthony elias, md | esmo22 colorado
-
2:02
dr. soliman the utility of adcs in breast cancer
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
2:59
trial demonstrates high efficacy of antibody drug conjugate in preventing early stage breast cancer
-
28:19
s3 episode 4: the future of antibody-drug conjugates in lung cancer treatment